Postmenopausal Breast Cancer Risk in Relation to Antibodies Specific to Benzo[a]Pyrene, Estradiol and Progesterone | Zendy

Andrew N. Glushkov | Zendy; Е. Г. Поленок | Zendy; M. V. Kostyanko | Zendy; А В Антонов | Zendy; N. Е. Verzhbitskaya | Zendy; И. А. Вафин | Zendy; С. Е. Рагожина | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Postmenopausal Breast Cancer Risk in Relation to Antibodies Specific to Benzo[a]Pyrene, Estradiol and Progesterone

Author(s) -

Andrew N. Glushkov,

Е. Г. Поленок,

M. V. Kostyanko,

А В Антонов,

N. Е. Verzhbitskaya,

И. А. Вафин,

С. Е. Рагожина

Publication year - 2016

Publication title -

iranian journal of cancer prevention

Language(s) - English

Resource type - Journals

eISSN - 2008-2401

pISSN - 2008-2398

DOI - 10.17795/ijcp-4212

Subject(s) - medicine , breast cancer , antibody , cancer , carcinogen , benzo(a)pyrene , postmenopausal women , immunoassay , endocrinology , immunology , chemistry , biochemistry

Immunoassay of antibodies against environmental carcinogens and sex steroid hormones could use to detect breast cancer risk. Induction of antibodies against Bp for cancer immunoprevention could lead to antibody formation against steroid hormones, thereby increasing breast cancer risk.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research